Literature DB >> 6767029

Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.

D H Rich, E T Sun, E Ulm.   

Abstract

Analogues of the carboxyl protease inhibitor, pepstatin, were synthesized from optically pure forms of N-(tert-butoxycarbonyl)-4-amino-3-hydroxy-6-methylheptanoic acid (Boc-Sta), and the inhibition of pepsin and renin was determined. In addition, the new amino acid (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid [AHPPA] was synthesized and the stereochemistry of the 3 and 4 positions established. The tripeptides isovaleryl-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-L-alanine isoamylamide [Iva-Val-(3S,4S)-Sta-Ala-NHiC5H11] and Iva-Val-(3S,4S)-AHPPA-Ala-NHiC5H11 were found to be potent inhibitors of pepsin with Ki = 1 x 10(-9) and 0.9 x 10(-9) M, respectively. Changing the chirality of the (3S)-hydroxy group to 3R or shortening the peptide chain diminished binding to pepsin over 100-fold. Three structural requirements necessary for potent inhibition of pepsin are proposed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767029     DOI: 10.1021/jm00175a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

Authors:  D Bailey; J B Cooper
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

2.  The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.

Authors:  J Kay; E G Afting; T Aoyagi; B M Dunn
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

3.  Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease.

Authors:  G Neil Stowe; Peter Silhár; Mark S Hixon; Nicholas R Silvaggi; Karen N Allen; Scott T Moe; Alan R Jacobson; Joseph T Barbieri; Kim D Janda
Journal:  Org Lett       Date:  2010-02-19       Impact factor: 6.005

4.  Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.

Authors:  B Veerapandian; J B Cooper; A Sali; T L Blundell; R L Rosati; B W Dominy; D B Damon; D J Hoover
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

5.  Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

Authors:  G B Dreyer; B W Metcalf; T A Tomaszek; T J Carr; A C Chandler; L Hyland; S A Fakhoury; V W Magaard; M L Moore; J E Strickler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.

Authors:  D Bailey; J B Cooper; B Veerapandian; T L Blundell; B Atrash; D M Jones; M Szelke
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

7.  New renin inhibitors homologous with pepstatin.

Authors:  M Eid; G Evin; B Castro; J Menard; P Corvol
Journal:  Biochem J       Date:  1981-08-01       Impact factor: 3.857

8.  Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.

Authors:  M N James; A Sielecki; F Salituro; D H Rich; T Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Nano-ZnO catalyzed multicomponent one-pot synthesis of novel spiro(indoline-pyranodioxine) derivatives.

Authors:  Harshita Sachdeva; Rekha Saroj; Diksha Dwivedi
Journal:  ScientificWorldJournal       Date:  2014-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.